← feed

Is NCT03341884 results overdue?

Yes — results are overdue. Primary completion was 2018-06-26; the FDAAA-801 reporting deadline (2019-06-26) passed 2598 days ago and no results are posted on ClinicalTrials.gov.

A Study of Ipatasertib in Participants With Mild, Moderate or Severe Hepatic Impairment Compared to Healthy Participants

NCT IDNCT03341884 ↗
SponsorGenentech, Inc. (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2018-06-26 (ACTUAL)
Reporting deadline2019-06-26 (completion + 365d)
Days overdue2598
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 8b38682525c91afa… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03341884. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →